Parkinson’s Disease:  A New Study Focusing on Preventing the Loss of Dopamine Producing Neurons
source: pixabay.com

Parkinson’s Disease:  A New Study Focusing on Preventing the Loss of Dopamine Producing Neurons

  The drug levodopa and most other therapies developed over the years for Parkinson's disease have been centered on correcting the lack of dopamine. Researchers acknowledge that the reason dopamine…

Continue Reading Parkinson’s Disease:  A New Study Focusing on Preventing the Loss of Dopamine Producing Neurons
Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
Pexels / Pixabay

Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis

  A news release from Benzinga shares that biotechnology company Emerald Health Pharmaceuticals is beginning a Phase 2 clinical study on EHP-101 as a treatment for patients with systemic sclerosis.…

Continue Reading Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis